It is a pleasure to follow the very powerful contribution of the hon. Member for West Dunbartonshire (Martin Docherty-Hughes). As a Greenockian myself, I certainly pay tribute to the heritage of the Clyde shipbuilders.
I am pleased to support today’s motion, which would uprate the payments made to sufferers of mesothelioma and other asbestos-related diseases. Members have already spoken about the absolutely devastating impact of these terrible diseases on both the sufferers and their families. It is particularly sobering that The Guardian reported that, alongside Australia, the UK had the highest rates of mesothelioma in the world in 2019. According to the National Asbestos Helpline, 13 people in the UK die every day from conditions that were caused by exposure to asbestos. That is more than twice the number of people killed daily in road accidents.
It is important for us to reflect on the failure of this place, and across the country, to appreciate the dangers of asbestos. The link between asbestos and other related diseases was first established in the 1950s, but it took another 40 years for a UK-wide ban to be enforced. Despite the ban, asbestos is still all around us, and that is quite literally the case for the building that we are in right now, and also for other public buildings such as hospitals and schools.
The Health and Safety Executive plays a key role in such assessments, but, as other Members have highlighted, its funding has been slashed and the number of inspectors has dropped significantly, too. The HSE also plays an important role in research around these and other occupational-related diseases, and I urge the Minister to address that issue in his wind-up.
It is, of course, entirely right that these schemes are under discussion today to ensure that sufferers of asbestos-related illnesses are compensated. None the less, there is an outstanding issue regarding the equalisation of payments to dependants who make a claim after somebody who has had one of the illnesses has died. This is a question of fairness, which is, after all, why the schemes were established to begin with. Will the Minister set out whether further consideration has been given to the issue of equalisation?
We must also reflect on the level of uprating, which is in line with inflation and other disability benefits that have already been passed in this place. When the uprating statutory instrument came through the House, I spoke of the importance of ensuring that legacy benefits and also carer’s allowance received additional uplifts, in line with the universal credit uplift, to reflect the impact that the pandemic has had disproportionately on these groups.
The same argument very much applies to the sufferers of asbestos-related illnesses and their families. Diagnoses such as these are incredibly difficult at any time for the person in question and their family. I can only imagine the incredible pain and trauma during a period such as this where restrictions mean being able to see only a very limited number of people. We must acknowledge just how difficult such diagnoses are for the person and for their family at all times, and especially over the past year, and it is right that support is there to reflect that. That will be particularly true for diseases such as mesothelioma, for which the life expectancy for sufferers is sadly very poor.
Early detection is incredibly important for occupational lung-related diseases, as it is for all such diseases and cancers. The national lockdowns will undoubtedly have had a huge impact on people coming forward with symptoms to get checked. I pay tribute to the fantastic work of my hon. Friend the Member for Westmorland and Lonsdale (Tim Farron) to make the case in this place for catching up with cancer, and to all the many charities and groups that have been making that argument, too. I urge the Government to bring forward further measures to ensure that we catch up with the national cancer backlog. One way that can be done is through proper investment in our healthcare service and cancer services. I hope the Chancellor will address the issue in the Budget tomorrow.
Finally, I note the work to support sufferers that the Minister outlined in his opening remarks, but ask him to address this point. On the uplift in the regulations, will he set out how he has taken into account the impact of covid-19 on people with mesothelioma and other asbestos-related diseases, in terms of not only the direct impact on health outcomes for sufferers in relation to covid-19—which is, after all, a respiratory virus—but the indirect impact caused by shielding, increased costs and fewer opportunities to get symptoms checked?
3.5 pm